ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 32, Issue 1, 2007, Pages 1-8

  De Leyn, Paul ^a   Lardinois, Didier ^b   Van Schil, Paul E ^c   Rami Porta, Ramon ^d   Passlick, Bernward ^e   Zielinski, Marcin ^f   Waller, David A ^g   Lerut, Tony ^a   Weder, Walter ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d HOSPITAL MÚTUA DE TERRASSA   (Spain)

^e UNIVERSITY OF FREIBURG   (Germany)

^f PULMONARY HOSPITAL   (Poland)

^g GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Intra operative staging; Lung cancer; Mediastinoscopy; Preoperative staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC PROCEDURE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINOSCOPY; MORBIDITY; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; ULTRASOUND;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDIASTINOSCOPY; MEDIASTINUM; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249913177     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.01.075     Document Type: Article

References (42)

1. Lardinois D., De Leyn P., Van Schil P.E., Rami Porta R., Waller D., Passlick B., Zielinski M., Junker K., Rendina E., Ris H.B., Hasse J., Detterbeck F., Lerut T., and Weder W. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 30 (2006) 787-792
2. De Leyn P., Vansteenkiste J., Cuypers P., Deneffe G., Van Raemdonck D., Coosemans W., Verschakelen J., and Lerut T. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 12 (1997) 706-712
3. Toloza E.M., Harpole L., and McCrory D.C. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (2003) 137S-146S
4. Ghosh S., Nanjiah P., and Dunning J. Should all patients with non-small cell lung cancer who are surgical candidates have cervical mediastinoscopy preoperatively?. Interactive Cardiovasc Thorac Surg 5 (2006) 20-24
5. Birim O., Kappetein A.P., Stijnen T., and Bogers A.J. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg 79 (2005) 375-382
6. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., Dupont P.J., Verschakelen J.A., Nackaerts K.L., and Mortelmans L.A. Mediastinal lymph node staging with FDG-PET scan in patients with operable non-small cell lung cancer. Chest 112 (1997) 1480-1486
7. Gupta N.C., Rogers J.S., Graeber G.M., Gregory J.L., Waheed U., Mullet D., and Atkins M. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 122 (2002) 1918-1924
8. Verhagen A.T., Bootsma G.P., Tjan-Heijnen V.C.G., van der Wilt G.J., Cox A.L., Brouwer M.H.J., Corstens F.H.M., and Oyen W.J.G. FDG-PET in staging lung cancer. How does it change the algorithm?. Lung cancer 44 (2004) 175-181
9. De Langen A.J., Raijmakers P., Riphagen I., Paul M.A., and Hoekstra O.S. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 29 (2006) 26-29
10. Serra M, Cirera L, Rami-Porta R, Basts R, Gonzalez S, Simo M, Domenech M, Barbeta E, Sloer JM, Belda J. Routine positron emission tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in non-small cell lung cancer. Abstract No. 7031, JCO 2006 Annual Meeting Proceedings 371s.
11. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., von Schulthess G.K., and Steinert H.C. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
12. De Leyn P., Stoobants S., Dewever W., Lerut T., Coosemans W., Decker G., Nafteux P., Van Raemdonck D., Mortelmans L., Nackaerts K., and Vansteenkiste J. Prospective comparative study of integrated PET-CT with remediastinoscopy in the assessment of residual mediastinal disease after induction chemotherapy for mediastinoscopy proven stage IIIa-N2 non-small cell lung cancer. J Clin Oncol 24 (2006) 3333-3339
13. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
14. Detterbeck F.C., Jones D.R., and Parker Jr. L.A. Intrathoracic staging. In: Detterbeck F.C., Rivera M.P., Socinski M.A., and Roseman J.G. (Eds). Diagnosis and treatment of lung cancer. An evidence-based guide for the practicing clinician (2001), WB Saunders Company, Philadelphia 73-93
15. Smulders S.A., Smeenk F.W.J.M., Janssen-Heijnen M.L.G., Wielders P.L., de Munck D.R., and Postmus P.E. Surgical mediastinal staging in daily practice. Lung Cancer 47 (2005) 243-251
16. Toloza E.M., Harpole L., and Detterbeck F. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 (2003) 157S-166S
17. De Leyn P., and Lerut T. Videomediastinoscopy. Multimedia Man Cardiothorac Surg (2004) 10.1510/mmcts.2004.000166
18. Mouroux J., Venissac N., and Alifano M. Combined video-assisted mediastinoscopy and video-assisted thoracoscopy in the management of lung cancer. Ann Thorac Surg 72 (2001) 1698-1704
19. Lardinois D., Schallberger A., Betticher D., and Ris H.B. Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer. Ann Thorac Surg 75 (2003) 1102-1106
20. Martin-Ucar A.E., Chetty G.K., Vaughan R., and Waller D.A. A prospective audit evaluating the role of video-assisted cervical mediastinoscopy (VAM) as a training tool. Eur J Cardiothorac Surg 26 (2004) 393-395
21. Hürtgen M., Friedel G., Tomes H., and Fritz P. Radical video-assisted mediastinoscopic lymphadenectomy (VAMLA)-technique and first results. Eur J Cardiothorac Surg 21 (2002) 348-351
22. Kuzdzal J., Zielinski M., Papla B., Szlubowski A., Hauer L., Nabialek T., Sosnicki W., and Pankowski J. Transcervical extended mediastinal lymphadenectomy - the new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg 27 (2005) 384-390
23. Holty J.E.C., Kuschner W.G., and Gould M.K. Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax 60 (2005) 949-955
24. Annema J.T., Verteegh M.I., Veselic M., Voigt P., and Rabe K.F. Endoscopic ultrasound fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging. J Clin Oncol 23 (2005) 8357-8361
25. Albain K.S., Swann R.S., Rusch V.R., Turrisi A.T., Shepherd F.A., Smith C.J., Gandara D.R., Johnson D.H., Green M.R., Miller R.C., and North American Lung Cancer Intergroup. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) versus CT/RT followed by surgical resection for stage IIIA (pN2) nonsmall cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). Oncologist 11 (2006) 43
26. Van Meerbeeck J.P., Kramer G., Van Schil P.E., Legrand C., Smit E.F., Schramel F.M., Biesma B., Tjan-Heijnen V.C., van Zandwijk N., Giaccone G., and EORTC-Lung Cancer Group. A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 nonsmall cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941). Oncologist 11 (2006) 42-43
27. Mateu-Navarro M., Rami-Porta R., Bastus-Piulats R., Cirera-Nogueras L., and Gonzalez-Pont G. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg 70 (2000) 391-395
28. Akhurst T., Downey R.J., Ginsberg M.S., Gonen M., Bains M., Korst R., Ginsberg R.J., Rush V.W., and Larson S.M. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 73 (2002) 259-266
29. Ryu J.S., Choi N.C., Fischman A.J., Lynch T.J., and Mathisen D.J. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer 35 (2002) 179-187
30. Cerfolio R.J., Ojha B., Mukherjee S., Pask A.H., Bass C.S., and Katholi C.R. Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. J Thorac Cardiovasc Surg 125 (2003) 938-944
31. Port J.L., Kent M.S., Korst R.J., Keresztes R., Levin M.A., and Altorki N.K. Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer. Ann Thorac Surg 77 (2004) 254-259
32. Hellwig D., Graeter T.P., Ukena D., Georg T., Kirsch C.M., and Schafers H.J. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma. J Thorac Cardiovasc Surg 128 (2004) 892-899
33. Cerfolio R.J., Bryant A.S., and Ojha B. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg 131 (2006) 1229-1235
34. Van Schil P., Van Der Schoot J., Poniewierski J., Pauwels M., Carp L., Germonpre P., and De Backer W. Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer 37 (2002) 281-285
35. Stamatis G., Fechner S., Hillejan L., Hinterthaner M., and Krbek T. Repeat mediastinoscopy as a restaging procedure. Pneumologie 59 (2005) 862-866
36. Pitz C.C.M., Maas K.W., Van Swieten H.A., de la Riviere A.B., Hofman P., and Schramel F.M. Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer. Ann Thorac Surg 74 (2002) 164-169
37. De Leyn P., Lerut T., and Vansteenkiste J. In reply. J Clin Oncol 24 (2006) 5339-5340
38. Jaklitsch M.T. Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA-N2 NSCLC: results of CALGB 39803. J Clin Oncol 23 16S (2005) 636s (abstract 7065)
39. Annema J.T., Veselic M., Versteegh M.I.M., Willems L.N.A., and Rabe K.F. Mediastinal restaging: EUS-FNA offers a new perspective. Lung Cancer 42 (2003) 311-318
40. Bueno R., Richards W.G., Swanson S.J., Jaklitsch J.M., Mentzer S.J., and Sugarbaker D.J. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70 (2001) 1826-1831
41. Betticher D.C., Hsu Schmitz S.F., Totsch M.H., Hanssen E., Joss C., von Briel C., Schmid R.A., Pless M., Habicht J., Roth A.D., Spiliopoulos A., Stahel R., Weder W., Stupp R., Egli F., Furrer M., Honegger H., Wernli M., Cerny T., and Ris H.B. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 (2003) 1752-1759
42. Lorent N., De Leyn P., Lievens Y., Verbeken E., Nackaerts K., Dooms C., Van Raemdonck D., Anrijs B., and Vansteenkiste J. Long-term survival of surgically staged IIIA-N2 non-small cell lung cancer treated with surgical combined modality approach: analysis of a 7-year experience. Ann Oncol 15 (2004) 1645-1653